Oasmia has been listed on the NGM Nordic MTF since 30th December 2005. Based on the company's strong growth and development, along with requests from both institutional and private investors, Oasmia is now initiating a transfer to an official listing. The company will during the coming months evaluate alternatives, and provide a final decision regarding the future listing in March 2007. For more information, contact: Oasmia Pharmaceutical AB, +46 18 505440 or info@oasmia.com Oasmia Pharmaceutical (publ) is a pharmaceutical company based on the latest concepts in bio-organic chemistry. The company idea is to improve treatment of serious conditions, with a focus on oncology. This is done through development of semi-synthesised substances to a new generation of effective pharmaceuticals for various areas of therapy. Oasmia is noted on the NGM Nordic MTF. More information is available at www.ngm.se or at www.oasmia.com.
OASMIA: OASMIA PHARMACEUTICAL AB (PUBL) PLANS TRANSFER TO OFFICIAL LISTING
| Source: Oasmia Pharmaceutical AB